Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
34.56
+1.71 (5.21%)
At close: Dec 5, 2025, 4:00 PM EST
35.23
+0.67 (1.94%)
After-hours: Dec 5, 2025, 7:18 PM EST

Structure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-210.69-122.53-89.62-51.32-38.05-15.88
Depreciation & Amortization
1.2110.320.280.07-
Other Amortization
----0.050.02
Loss (Gain) From Sale of Investments
-18.85-18.47-5.98-0.910.030.03
Stock-Based Compensation
26.7518.798.192.511.490.57
Other Operating Activities
2.071.60.630.350.190.02
Change in Accounts Payable
9.353.31-0.862.151.91.02
Change in Other Net Operating Assets
-4.09-0.347.830.822.17-0.07
Operating Cash Flow
-194.25-116.64-79.49-46.12-32.16-14.28
Capital Expenditures
-2.13-1.29-2.17-0.16-1.21-0.02
Investment in Securities
63.86-357.62-266.18-61.9519.07-21.13
Investing Cash Flow
66.89-358.91-268.34-62.1117.86-21.15
Issuance of Common Stock
59.53517.06473.10.030.01-
Repurchase of Common Stock
-0.62---0.01--
Other Financing Activities
-0.77-1.8-21.57-2.513.24-0.16
Financing Cash Flow
58.14515.26451.5329.01103.2525.84
Net Cash Flow
-69.2239.72103.7-79.2188.95-9.59
Free Cash Flow
-196.38-117.93-81.66-46.28-33.37-14.3
Free Cash Flow Per Share
-3.40-2.24-2.22-14.48-12.30-6.85
Levered Free Cash Flow
-112.54-70.78-51.38-26.08-18.79-
Unlevered Free Cash Flow
-112.54-70.78-51.38-26.08-18.76-
Change in Working Capital
5.262.966.972.974.060.95
Source: S&P Capital IQ. Standard template. Financial Sources.